Corporate Dynamics founded a company servicing the pharmaceutical and biotech industries.The company registers, promotes and distributes innovative pharmaceutical products in Romania for large Pharma and Biotech Companies. Since its creation, Geneva Romfarm International has worked with such companies as Abbott Laboratories, Merck Serono, Jansen, Actelion, Rhodia, Piramal.Geneva Romfarm International has been successful in creating and enlarging the market for the innovative treatments and, by doing so, bettering the lives of thousands of patients.
For over twenty years Geneva Romfarm International has been actively, importing, registering, promoting and distributing in Romania, some of the World’s most innovative treatments. With a field of expertise ranging from general medicine, to the very specialized tasks of introducing revolutionary drugs for rare diseases, the company is held in the highest regards by the country’s leading physicians, healthcare authorities and patient associations. We believe that by fostering and maintaining strong ties with patient and professional associations, we achieve an unsurpassed level of feedback from the market that actively plays a role in the way the company acts and reacts to environmental changes. We also believe in our ethical and civic responsibilities to educate and collaborate with all of our stakeholders.
Geneva Romfarm International created and developed markets for orphan drugs, therapies dedicated to rare diseases as Pulmonary Arterial Hypertension (PAH) and Multiple Sclerosis (MS).
“Orphan drugs” are pharmaceutical products intended for prevention or treatment of life-threatening or debilitating rare diseases. They are “orphans” because there is little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.